Inhibition of Adipogenesis and Induction of Apoptosis and Lipolysis by Stem Bromelain in 3T3-L1 Adipocytes

Abstract

The phytotherapeutic protein stem bromelain (SBM) is used as an anti-obesity alternative medicine. We show at the cellular level that SBM irreversibly inhibits 3T3-L1 adipocyte differentiation by reducing adipogenic gene expression and induces apoptosis and lipolysis in mature adipocytes. At the molecular level, SBM suppressed adipogenesis by downregulating C/EBPα and PPARγ independent of C/EBPβ gene expression. Moreover, mRNA levels of adipocyte fatty acid-binding protein (ap2), fatty acid synthase (FAS), lipoprotein lipase (LPL), CD36, and acetyl-CoA carboxylase (ACC) were also downregulated by SBM. Additionally, SBM reduced adiponectin expression and secretion. SBM's ability to repress PPARγ expression seems to stem from its ability to inhibit Akt and augment the TNFα pathway. The Akt–TSC2–mTORC1 pathway has recently been described for PPARγ expression in adipocytes. In our experiments, TNFα upregulation compromised cell viability of mature adipocytes (via apoptosis) and induced lipolysis. Lipolytic response was evident by downregulation of anti-lipolytic genes perilipin, phosphodiestersae-3B (PDE3B), and GTP binding protein Giα1, as well as sustained expression of hormone sensitive lipase (HSL). These data indicate that SBM, together with all-trans retinoic-acid (atRA), may be a potent modulator of obesity by repressing the PPARγ-regulated adipogenesis pathway at all stages and by augmenting TNFα-induced lipolysis and apoptosis in mature adipocytes.

Oleic Acid May Be the Key Contributor in the BAMLET-Induced Erythrocyte Hemolysis and Tumoricidal Action

“…MTT assay was performed as described previously [25]. Briefly, Cells were seeded at 5,000 cells/well on 96-well plates and incubated for 24 to 48 h before the treatment.…”

Effect of Gambisan on the Inhibition of Adipogenesis in 3T3-L1 Adipocytes

“…In the present study, the anti-obesity effect of Gambisan and its mechanism of action were investigated in differentiating mouse 3T3-L1 adipocytes [23], a basic and robust model to assess adipogenesis and adipocyte metabolism in vitro , by measuring viability, TG deposition, lipid droplet accumulation in the treated cells, and expression levels of several adipocyte-specific genes [24] including hormone-sensitive lipase (HSL) and lipoprotein lipase (LPL) and major adipogenic transcriptional factors [25] including peroxisome proliferator-activated receptor gamma (PPAR γ ), CCAAT/enhancer binding protein alpha (C/EBP α ), and sterol regulatory element binding protein-1 (SREBP-1).…”

Role of PPARγ in the nutritional and pharmacological actions of carotenoids

“…SBM, together with atRA, may be a potent modulator of obesity by repressing the PPARγ-regulated adipogenesis pathway at all stages and by augmenting TNFα-induced lipolysis and apoptosis in mature adipocytes. 54 In addition, Lee et al reported that RA inhibited BMP4-induced C3H10T1/2 mesenchymal stem cell adipogenic commitment and differentiation, as observed by reductions in key adipogenic genes/transcription factors (C/EBPα, PPARγ, aP2), lipogenic genes (LPL, FAS, GLUT4), and lipid accumulation. RA significantly suppressed the BMP4-triggered phosphorylation of both Smad1/5/8 and p38MAPK.…”